General pool drug testing consortium vs standalone program
Wisconsin Eagle/10240937

GREEN BAY, Wis. - WisconsinEagle -- The number of covered employees may impact your decision on which to use

Participating in a drug testing consortium is a great way for small employers and owner-operators to take advantage of larger consortium pool numbers with regard to meeting random DOT drug test requirements. However, at what point does it make sense for a growing company to move to a standalone program?

Wisconsin Drug Testing Consortium (WDTC) provides services as a drug testing consortium manager as well as through standalone programs. While there is no fixed number of covered employees needed before transitioning to a standalone program, we recommend looking into that model once your number reaches 25 or more covered employees.

It is common for decision makers to focus solely on compliance and cost when it comes to DOT drug testing for employees who operate in the DOT environment. The third leg of that stool is safety, and this is where moving to a standalone testing program can increase safety benefits over a general pool drug testing consortium.

More on Wisconsin Eagle

• Robert Fabbio Inducted into the Austin Technology Council Hall of Fame
• Cybersecurity is Protecting Your Personal Information and Your Portfolio
• L2 Aviation Celebrates Grand Opening of New Facility at Cincinnati/Northern Kentucky International Airport (CVG)
• Managing Summer Staffing Surges with Confidence: Why Name Badges Are a Must for Seasonal Success
• Visa Named Title Sponsor of Ascending Athletes' Business Owners Summits for NFL Entrepreneurs

Drug testing consortium safety benefits decline with more employees

DOT testing percentages states that 50 percent of your covered employees must undergo random drug tests and 10 percent alcohol tests each calendar year. Participating in a general pool drug testing consortium typically reduces that percentage for each participating employer and it dilutes the percentage of employees from larger companies who otherwise would be tested.

For example, a company using a standalone program with 20 covered employees would need 10 employees to be randomly drug tested and two alcohol tested. Remaining in a drug testing consortium likely would reduce the number of tested employees and impact overall safety.

"Moving to a standalone program involves a minimal cost increase to stay compliant, and it would be a decision driven by safety," notes Mike Bray, president of WDTC. "Utilizing a standalone consortium instead of a general pool consortium becomes an investment in your company's overall safety culture."

About Wisconsin Drug Testing Consortium

More on Wisconsin Eagle

• The Paris Court of International Arbitration Elects Dr. John J. Maalouf as its New President
• $56.7 Million Announced in Q1 2025 with Revenue Growth and Progress Toward NASDAQ Uplisting for AI Marketing Company: IQSTEL, Inc. Stock Symbol: IQSTD
• When The Call Hits Home Podcast Features Tom Rizzo
• SAVVY MINING raised $500 million and launched BTC.XRP.DOGE cloud mining, increasing investors' returns by 30%
• New National Nonprofit Launches to Capture Firsthand Accounts of Adoption Stories

Wisconsin Drug Testing Consortium is an accredited, Certified Third Party Administrator (C-TPA), and specializes in DOT consortium management and Clearinghouse compliance; 100% electronic from your desktop portal; a variety of drug testing methods, including urine, hair and fingernails; post-accident testing; pre-employment drug tests; criminal background checks; supervisor training programs to keep employees compliant with DOT regulations; pre-employment DOT physicals; and paternity DNA testing.

Headquartered in Green Bay, WDTC also has offices in Oshkosh and Appleton, Wisconsin. Call 920-393-4168 or visit https://widrugtesting.com for more information.

View the original post on drug testing consortium here.